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Abstract
Objectives—To examine the association between cerebral hyperintensities and cerebrovascular
risk factors (CVRF) among middle-aged and older adults with major depressive disorder (MDD).
Methods—Thirty patients (aged 55–77 years) with MDD and no history of stroke participated in
a magnetic resonance imaging assessment to assess for the presence of cerebral hyperintensities
and underwent a physical examination to assess stroke risk as indexed by the Framingham Stroke
Risk Profile (FSRP). In addition, intima medial thickness (IMT) was measured in the left and right
carotid arteries.
Results—Higher FSRP levels were associated with total greater cerebral hyperintensities (r =
0.64), as well as greater subependymal hyperintensities (r = 0.47), confluent periventricular
changes (r = 0.46), and tended to be associated with subcortical gray matter hyperintensities (r =
0.34). A quadratic relationship was observed between IMT and total cerebral hyperintensities (b =
4.84), and higher IMT levels were associated with greater subependymal hyperintensities (r =
0.40).
Conclusions—Higher levels of CVRF are associated with graded increases in cerebral
hyperintensities among middle-aged and older adults with MDD.
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Major depressive disorder (MDD) is the leading cause of disability in the United States1 and
has been associated with greater cerebrovascular risk factors (CVRF) and subclinical
vascular disease.2 Older individuals with MDD are often characterized by increased
frequency of cerebral hyperintensities seen on magnetic resonance imaging (MRI), as well
as a later onset of first depressive episode.3 Although previous studies among healthy adults
have demonstrated a dose–response association between CVRF and cerebral
hyperintensities,4 the graded nature of this relationship has not been evaluated in patients
with MDD in which case–control methodologies have been widely used. Therefore, we
investigated the relationship between CVRF and cerebral hyperintensities among 30 adults
with MDD, aged 55 years and older. We hypothesized that higher levels of CVRF would be
associated with greater cerebral hyperintensities.
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The sample examined in this report represents a subset of individuals from a larger clinical
trial among middle-aged and older adults with MDD.5 The current analysis is limited to
those individuals (N = 30) who volunteered for MRI assessments at baseline. The inclusion
criteria includes age at least 55 years with MDD based on clinician-diagnosed Diagnostic
and Statistics Manual fourth edition criteria. Exclusion criteria have been detailed elsewhere.
5
Cerebrovascular Risk Factors
Framingham Stroke Risk Profile—The Framingham Stroke Risk Profile (FSRP), a risk
assessment tool used to assess the risk of incident stroke, was used as an index of CVRF.6
Risk factors used to assess stroke risk include systolic blood pressure (SBP), use of
antihypertensive therapy, diabetes mellitus, cigarette smoking, cardiovascular disease, and
atrial fibrillation.6 Details of our CVRF assessments have been previously reported.7
Intima Medial Thickness of the Carotid Arteries—Carotid artery intima medial
thickness (IMT) was assessed by high-resolution B-mode ultrasound using an Acuson Aspen
(Mountain View, CA) vascular imaging system with 10-MHz linear array transducer.
Ultrasound examinations of the far wall of the left and right common carotid arteries were
used to acquire longitudinal images spanning 2 cm proximal to the carotid bulb. IMT of the
far wall of the left and right common carotid arteries was measured over a 1-cm segment
using Carotid Analyzer 5.0.5 (Medical Imaging Applications LLC, Iowa City, IA) edge
detection software. Far wall measurements only were used as near wall measurements have
been shown to have limited reliability.
Hyperintensities in the Brain
Magnetic Resonance Imaging—Participants were assessed using a 1.5 Tesla whole-
body MRI system with standard head coil and an anterior neck coil for the carotid vascular
imaging. The examination included a standard clinical assessment of the brain that gathered
T1-weighted, T2-weighted, and proton-density-weighted images for assessment of brain
pathology. Calibration standards for T2 (80 and 120-msec T2 values) were included within
the field of view. The first set of images was obtained with an axial, multisection, T1-
weighted pulse sequence (TR= 500 msec, TE= 15 msec) with a 256 × 256 matrix, 5-mm
section thickness with a 7.5-mm distance between section centers, a 20-cm field of view,
and 1 excitation per phase-encoding increment. This was followed by a long TR (2500
msec), double-echo (TE= 30 and 80 msec) spin-echo data-acquisition sequence using the
same field of view, section thickness, and spacing, with flow compensation gradients, 256 ×
256 matrix, using conjugate synthesis (half-Fourier). Saturation of spins outside the imaging
volume (standard gap 15 mm) and flow compensation (gradient moment nulling) were used
to eliminate artifacts due to flowing blood and CSF. Aliasing in the frequency-encoding axis
was eliminated by oversampling and filtration. The studies were filmed and archived by a
trained technologist.
Lesion ratings were performed by two experienced clinicians, blinded to participants’
treatment assignment, using the Boyko lesion classification system,8 which assesses cerebral
hyperintensities as follows: frontal caps: 0 = absent, 1 = present; sub-ependymal
hyperintensities: 0 = absent, 1 = thin, 2 = thick >2 mm; confluent periventricular changes: 0
= absent, 1 = hypointense to gray matter and hyperintense to CSF on proton density images,
2 = isointense to gray matter and hyperintense to CSF on proton density images, 3 =
hyperintense to CSF on T2 weighted images, 4 = hyperintense to CSF on T2-weighted
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images and isointense to CSF on T1-weighted images; deep white matter hyperintensities: 0
= absent, 1 = punctate, 2 = rounded <5 mm, 3 = irregular >5 mm, 4 = confluent lesions; and
subcortical gray matter hyperintensities: 0 = absent, 1 = punctate, 2 = rounded <5 mm, 3 =
irregular >5 mm, 4 = confluent lesions. Prior studies from our group have consistently
demonstrated interrater reliability of >0.80 on each of the hyperintensity item ratings. All
participants were screened by the technologist for the presence of cardiac pacemakers,
neurostimulants, metallic implants, metal in the orbit, aneurysm clips, or any other
circumstance for which MRI was contraindicated.
Assessment of Depression
The presence of MDD was determined by a trained clinical psychologist using the
Diagnostic Interview Schedule9 and the 17-item Hamilton Depression Rating Scale to assess
MDD severity. Assessments were performed by licensed clinical psychologists blinded to
the treatment condition. All participants met criteria for MDD based on Diagnostic and
Statistical Manual-IV.
Statistical Analysis
Data Reduction—To minimize the number of statistical models examining the association
between CVRF and cerebral hyperintensities, all hyperintensities were summed to create a
continuous criterion variable in our primary model. Supplementary analyses were conducted
within each lesion area only if the primary model demonstrated a significant relationship
between CVRF and total cerebral hyperintensities.
Data Analysis—For the purposes of our primary analysis, total cerebral hyperintensities
served as our criterion variable in a linear (Pearson) correlation analysis with FSRP levels as
the sole predictor. To determine the relationship between cerebral hyperintensities and IMT,
we estimated a general linear model with the continuous form of cerebral hyperintensities as
the response, IMT as the predictor of primary interest, and age as an adjustment covariate.
We examined model assumptions using graphical methods, modifying the model as
necessary.
Secondary analyses were conducted within each lesion location. Because only one
participant did not exhibit frontal caps during their MRI assessment, we were unable to
conduct secondary analyses within this lesion area. Spearman rank correlation was used to
examine the association among FRSP levels, IMT, and cerebral hyperintensities within each
lesion area due to non-normality of the distributions within individual lesion locations. In all
analyses, FSRP levels and IMT were scaled using the interquartile range, which allows the
parameter estimate to be interpreted as comparing a “typical” person in the middle of the
upper half of the predictor distribution with a “typical” person in the middle of the lower
half of the predictor distribution.
RESULTS
Sample Characteristics
Thirty individuals participated in MRI assessments, ranging in age from 55 to 77 years
(mean = 58.8 years, SD = 4.8). The primary reasons for not participating in MRI
assessments were age <55 years (79%), participant declined (13%), or medical
contraindications to participation (3.4%). Participants were mild-to-moderately depressed
(mean Hamilton Depression score = 16.3, SD = 5.3) and did not exhibit any gross cognitive
deficits. The majority of participants were female (66.7%), European American (83.3%),
and almost half were college educated (47.7%). Participants were generally in good health,
as indexed by relatively low levels of SBP (mean SBP = 126 mmHg, SD = 17) and LDL to
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HDL cholesterol ratio (mean ratio = 2.3, SD = 0.9), FSRP levels (mean FSRP score = 5.1,
SD = 2.7), and relatively low severity of cerebral hyperintensities (mean cerebral
hyperintensities = 3.1, SD = 2.2). No participants reported a history of stroke, and the
sample was also relatively free of cardiovascular comorbidities such as diabetes (6.7%),
arthritis (33.3%), and current tobacco use (23.3%).
CVRF and Cerebral Hyperintensities
Framingham Stroke Risk Profile—Higher FSRP levels were associated with total
greater cerebral hyperintensities (Pearson r30 = 0.64, p <0.001; Fig. 1). After controlling for
age, we found a significant correlation between increasing SBP levels and total cerebral
hyperintensities (t27 = 2.18, b = 1.22, p = 0.038). Supplementary analyses within each lesion
area demonstrated that higher FSRP levels were associated with greater subependymal
hyperintensities (Spearman r30 = 0.47, p = 0.009) and confluent periventricular changes
(Spearman r30 = 0.46, p = 0.011), but were not statistically significantly associated with
subcortical gray matter hyperintensities (Spearman r30 = 0.34, p = 0.066) or deep white
matter hyperintensities (Spearman r30 = 0.23, p = 0.215).
Intima Medial Thickness—On examining residuals from our primary model, we
observed strong evidence of nonlinearity between cerebral hyperintensities and IMT. Thus,
we estimated a model that included both a quadratic and linear term for IMT, along with the
age covariate. The quadratic relation was statistically significant (t26 = 2.08, b = 4.84, p =
0.047), such that the cerebral hyperintensities increased exponentially in the presence of
higher levels of IMT. In addition, supplementary analyses demonstrated that higher levels of
IMT were associated with greater subependymal hyperintensities (Spearman r30 = 0.40, p =
0.030), but were not statistically significantly related to confluent periventricular changes
(Spearman r30 = 0.25, p = 0.183), subcortical gray (Spearman r30 = −0.10, p = 0.595), or
deep white matter hyperintensities (Spearman r30 = 0.01, p = 0.957).
DISCUSSION
Results from this analysis demonstrate that greater CVRF are associated with greater
cerebral hyperintensities among middle-aged and older adults with MDD. These results
extend previous findings2 by demonstrating that a graded relationship exists between CVRF
and cerebral hyperintensities among individuals with MDD.
The relationship between cerebral health and depression has received increasing attention,
initially through “vascular depression” hypothesis by Alexopoulos et al. and recently by
Taylor et al. who recommended a new diagnostic classification of subcortical ischemic
depression.2 Although population-based studies have demonstrated that greater CVRF are
associated with greater white matter hyperintensities,4 to our knowledge, this is the first
study to demonstrate a graded relationship between CVRF and cerebral hyperintensities
among middle-aged and older individuals with MDD, despite similar findings among case–
control studies.10 This finding is important because it provides preliminary data that cerebral
damage may be observed at relatively low levels of cerebrovascular risk among older adults
with depression, indicating that the risk of depression and cerebral health may be
continuous, in contrast to the threshold relationship previously postulated.2 Taken together
with recent findings that the onset of depression and number of previous episodes are
associated with subclinical atherosclerosis, but not current depression severity,11 the current
findings provide evidence that risk of depression associated with vascular health exists on a
continuum, such that treatment of vascular risk factors may help prevent the occurrence of
depression in later life. Although preliminary, replication of these findings could have
important implications for treatment strategies among individuals at risk for late-life
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depression and provides further evidence that managing vascular risk factors is an important
treatment target warranting further investigation.12
We note that this preliminary report has several limitations. Because only 30 of the 54
qualified individuals chose to participate in the MRI portion of our study, the
generalizability of our findings is limited. In addition, our MRI protocol did not use a
FLAIR sequence, which would have improved the sensitivity of our scans to structural
damage. Finally, participants exhibited relatively low levels of cerebral hyperintensities and
few subependymal hyperintensities and confluent periventricular changes, in particular.
Therefore, the current analyses may have been underpowered to examine the relationship
between CVRFs and cerebral hyperintensities within specific lesion areas, such as deep
white matter hyperintensities. Therefore, the present findings must be viewed as preliminary
and should be examined in larger samples with a greater prevalence of cardiovascular
disease.
In summary, higher levels of CVRF are associated with greater cerebral hyperintensities
among middle-aged and older adults with MDD. Future studies should investigate the
prospective association between CVRF and cerebral hyperintensities to elucidate the causal
relationship between these factors. Moreover, future studies would benefit from the
inclusion of more sensitive measures of cerebral white matter damage, such as functional
MRI and diffusion tensor imaging, in assessing structural white matter changes among
individuals with MDD.
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